1. Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

   • Frederik A. Verburg
   • Markus Dietlein
   • Christoph Reiners

   Editorial 03 December 2008 Pages: 343 - 346

2. Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study

   • Andrew M. Scott
   • Dishan H. Gunawardana
   • Peter Robins

   Original Article 18 October 2008 Pages: 347 - 353

   

3. Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study

   • B. E. Chatterton
   • I. Ho Shon
   • A. M. Scott

   Original Article 18 October 2008 Pages: 354 - 361

   

4. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT

   • Kazuhiro Kitajima
   • Koji Murakami
   • Kazuro Sugimura

   Original Article 18 October 2008 Pages: 362 - 372

   

5. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma

   • Kotaro Higashi
   • Tsutomu Sakuma
   • Hisao Tonami

   Original Article 18 October 2008 Pages: 373 - 381

   

6. Detection of gastric cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET

   • Reiko Kameyama
   • Yuka Yamamoto
   • Yoshihiro Nishiyama

   Original Article 05 November 2008 Pages: 382 - 388

   

7. Reproducibility of quantitative ¹⁸F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography

   • Adrianus J. de Langen
   • Bianca Klabbers
   • Adriaan A. Lammertsma

   Original Article Open access 18 October 2008 Pages: 389 - 395

   

8. Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease

   • Nicolas Aide
   • Laurent Poulain
   • Françoise Montravers

   Original Article 03 December 2008 Pages: 396 - 405

   

9. Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity

   • Fijs W. B. van Leeuwen
   • Tessa Buckle
   • Kenneth G. A. Gilhuijs

   Original Article 18 December 2008 Pages: 406 - 412

   

10. Hybrid PET-dynamic CECT in the management of breast cancer

    • Rakesh Kumar
    • Chandan Jyoti Das

    Editorial Commentary 20 January 2009 Pages: 413 - 415

11. Metabolic–flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT

    • Ashley M. Groves
    • Gordon C. Wishart
    • Kenneth A. Miles

    Short Communication 26 September 2008 Pages: 416 - 421

    

12. ¹¹C-Acetate PET imaging for renal cell carcinoma

    • Nobuyuki Oyama
    • Hidehiko Okazawa
    • Osamu Yokoyama

    Short Communication 19 November 2008 Pages: 422 - 427

    

13. Monoamine transporter availability in Parkinson’s disease patients with or without depression

    • Swen Hesse
    • Philipp M. Meyer
    • Osama Sabri

    Original Article 27 November 2008 Pages: 428 - 435

    

14. Effects of long-term practice and task complexity on brain activities when performing abacus-based mental calculations: a PET study

    • Tung-Hsin Wu
    • Chia-Lin Chen
    • Jason J. S. Lee

    Original Article 05 November 2008 Pages: 436 - 445

    

15. Effect of cyclosporin A administration on the biodistribution and multipinhole μSPECT imaging of [¹²³I]R91150 in rodent brain

    • P. Blanckaert
    • I. Burvenich
    • F. De Vos

    Original Article 05 November 2008 Pages: 446 - 453

    

16. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls

    • S. A. Eshuis
    • P. L. Jager
    • K. L. Leenders

    Original Article Open access 27 November 2008 Pages: 454 - 462

    

17. Image-derived input functions for PET brain studies

    • Jurgen E. M. Mourik
    • Mark Lubberink
    • Ronald Boellaard

    Original Article 22 November 2008 Pages: 463 - 471

    

18. Testing for radioligand sensitivity to endogenous neurotransmitter release

    • Gitte M. Knudsen

    Editorial Commentary 27 January 2009 Pages: 472 - 474

19. The effects of d-amphetamine on extrastriatal dopamine D₂/D₃ receptors: a randomized, double-blind, placebo-controlled PET study with [¹¹C]FLB 457 in healthy subjects

    • Sargo Aalto
    • Jussi Hirvonen
    • Jarmo Hietala

    Original Article 05 November 2008 Pages: 475 - 483

    

20. Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?

    • Inga Buchmann
    • Ralf G. Meyer
    • Uwe Haberkorn

    Review Article 08 January 2009 Pages: 484 - 498

    

21. V/Q scintigraphy: alive, well and equal to the challenge of CT angiography

    • Leonard M. Freeman
    • Linda B. Haramati

    Editorial Commentary 30 January 2009 Pages: 499 - 504

22. Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT

    • John H. Reid
    • Emmanuel E. Coche
    • International Atomic Energy Agency Consultants’ Group

    Original Article 27 January 2009 Pages: 505 - 521

    

23. Diagnosing pulmonary embolism: clinical problem or methodological issue?

    • Giovanni Lucignani
    • Massimo Pistolesi

    Focus on 10 January 2009 Pages: 522 - 528

24. J.P. McGahan and B.B. Goldberg (eds): Diagnostic ultrasound (2nd edn.)

    • Orlando Catalano
    • Luigi Mansi

    Book Review 08 January 2009 Pages: 529 - 530

25. Ich bin ein Molekularmediziner (how much CT and nuclear medicine in molecular CT?)

    • Luigi Mansi

    Letter to the Editor 13 January 2009 Pages: 531 - 532

    

26. Will high-resolution/high-sensitivity SPECT ensure that PET is not the only survivor in nuclear medicine during the next decade?

    • Alain Seret

    Letter to the Editor 14 January 2009 Pages: 533 - 535

27. ‘Intensity diffusion’ is a better description than ‘partial volume effect’

    • Arne Skretting

    Letter to the Editor 21 January 2009 Pages: 536 - 537

28. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up

    • Shu-Hang Ng
    • Sheng-Chieh Chan
    • Cheng-Lung Hsu

    Erratum 13 February 2009 Pages: 538 - 538

29. FDG-PET in paraneoplastic limbic encephalitis

    • F. Troester
    • G. Weske
    • K. Kraemer

    Image of the Month 24 December 2008 Pages: 539 - 539

30. The new EANM paediatric dosage card

    • M. Lassmann
    • L. Biassoni
    • for the EANM Dosimetry and Paediatrics Committees

    Society Communications 04 February 2009 Pages: 540 - 541

31. Certificate of Fellowship of the European Board of Nuclear Medicine 2009 Information

    Society communications 31 January 2009 Pages: 542 - 550

32. Syllabus for postgraduate specialisation in Nuclear Medicine

    • Alberto Cuocolo
    • Metka Milčinski
    • Angelika Bischof Delaloy

    Society Communications 30 January 2009 Pages: 551 - 554